Am J Transplant, Volume 20, Suppl 3 Archives - Page 191 of 223 - ATC Abstracts

2020 American Transplant Congress
Pre-Transplant Detection of Anti-at1r Antibodies and Pediatric Kidney Transplantation Outcomes
K. Hitchman¹, C. Usenko², R. Hinojosa¹, D. Ranch¹
¹UT Health San Antonio, San Antonio, TX, ²University Health System, San Antonio, TX
*Purpose: Describe correlations between pre-transplant (PreTXP) presence of anti-angiotensin II receptor type 1 antibodies (AT1R Ab) and post-transplant (PostTXP) outcomes in a pediatric kidney transplant…
2020 American Transplant Congress
Effect of Discordant Kidney Function at Transplant: A Single Center Analysis of Deceased Donor Paired Kidneys
E. Abuhelaiqa¹, M. Alkadi¹, S. Mansour², L. Mathew¹, F. Makableh¹, A. Nauman¹, O. Fituri¹, M. Asim¹, R. Fadhil³, H. A. Al-Malki¹
¹Nephrology, Hamad Medical Corporation, Doha, Qatar, ²Internal Medicine, Hamad Medical Corporation, Doha, Qatar, ³Transplant Surgery, Hamad Medical Corporation, Doha, Qatar
*Purpose: Analysis of paired kidneys from deceased donors has the advantage of eliminating donor and center related biases seen in previous studies that evaluated kidney…
2020 American Transplant Congress
Metabolic Syndrome Predicts Worse Long-Term Renal Outcomes in Living Kidney Donors (LKDs)
M. Merzkani¹, A. Denic¹, M. D'Costa¹, L. Ricaurte¹, R. Narasimhan¹, X. Benavides¹, A. Mullan¹, J. Larson¹, W. Kremers¹, W. Park¹, M. P. Alexander¹, S. Textor¹, S. Taler¹, H. Chakkera², M. Stegall¹, N. Issa¹, A. Rule¹
¹Mayo Clinic, Rochester, MN, ²Mayo Clinic, Scottsdale, AZ
*Purpose: Prior studies linked metabolic syndrome with worse kidney outcomes in a variety of populations. In this study, we assessed the long-term risk of reduced…
2020 American Transplant Congress
Efficacy and Possible Risk of De Novo Use of Everolimus for Primary Kidney Transplantation
S. Narumi¹, Y. Watarai¹, N. Goto², T. Hiramtsu¹, M. Okada¹, K. Futamura², T. Tomosugi¹, A. Kanda², T. Kobayashi³
¹Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya City, Aichi Prefecture, Japan, ²Transplant Nephrology, Nagoya Daini Red Cross Hospital, Nagoya City, Aichi Prefecture, Japan, ³Transplant Surgery, Aichi Medical University School of Medicine, Nagakute City, Aichi Prefecture, Japan
*Purpose: Transplant outcome and protocol stay rate of everolimus were investigated to clarify efficacy and risk of everolimus based regimens at a single institute.*Methods: During…
2020 American Transplant Congress
Optimal Timing of Initiating Continuous Renal Replacement Therapy in Patients with Acute Kidney Injury after Liver Transplantation
A. Ren, Z. Li, X. Zhang, R. Deng, Y. Ma
Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
*Purpose: Acute kidney injury(AKI) is a frequent complication after liver transplantation(LT), and is associated with high mortality. Continuous Renal Replacement Therapy (CRRT) is a blood…
2020 American Transplant Congress
Temporal Trends in the Incidence and Impact of Biliary Complications Following Liver Transplantation
K. R. Jackson¹, K. Lentine², M. Schnitzler², Z. Zhang², H. Xiao², J. Motter¹, D. Axelrod³, D. Segev¹
¹Johns Hopkins University, Baltimore, MD, ²Saint Louis University, Saint Louis, MO, ³University of Iowa, Iowa City, IA
*Purpose: Biliary complications (BC) are a major threat to successful liver transplantation (LT), as they are associated with a subsequent higher risk of mortality and…
2020 American Transplant Congress
Impact of Pre-Liver Transplant Cardiovascular Disease Risk Assessment Standardization on Resource Utilization and Recipient Selection
J. Rice¹, D. Hughes¹, J. R. Burton¹, E. D. Pomfret², J. J. Pomposelli², A. V. Ambardekar³, M. Kriss¹
¹Division of Gastroenterology and Hepatology, University of Colorado School of Medicine, Aurora, CO, ²Division of Transplant Surgery, University of Colorado School of Medicine, Aurora, CO, ³Division of Cardiology, University of Colorado School of Medicine, Aurora, CO
*Purpose: Cardiovascular disease (CVD) risk assessment (RA) prior to liver transplantation (LT) is a critical aspect of recipient selection, however data on optimal testing is…
2020 American Transplant Congress
Phage Therapy for Mycobacterium Abscessus (Mab) Infection after Lung Transplant (LT)
W. Garner¹, R. Dedrick², C. Guerrero², M. Morrell¹, J. D'Cunha³, P. Sanchez¹, G. Hatfull², G. Haidar¹
¹University of Pittsburgh Medical Center, Pittsburgh, PA, ²University of Pittsburgh, Pittsburgh, PA, ³Mayo Clinic Arizona, Phoenix, AZ
*Purpose: LT recipients with Mab infections have poor outcomes. We describe a patient with refractory Mab infection treated with mycobacteriophage therapy.*Methods: A 56-year-old woman with…
2020 American Transplant Congress
Incidence of Oropharyngeal and Esophageal Candidiasis in Adult Kidney Transplant Recipients Receiving Nystatin versus No Prophylaxis
L. Moreno¹, K. Klein¹, C. Long², R. Hall¹, J. Nelson¹
¹Pharmacotherapy and Pharmacy Services, Pharmacotherapy Division, University Health System, The University of Texas Health Science Center at San Antonio, The University of Texas at Austin, College of Pharmacy, San Antonio, TX, ²Pharmacotherapy and Pharmacy Services, Pharmacy Practice, University Health System, University of the Incarnate Word Feik School of Pharmacy, San Antonio, TX
*Purpose: The purpose of this study is to evaluate the need for nystatin prophylaxis for oropharyngeal (OPC) and esophageal Candidiasis (EC) in adult kidney transplant…
2020 American Transplant Congress
Sequence Variations of the LMP1 Protein are Detected in Pediatric Transplant Recipients and May Increase the Risk of EBV Disease
B. Mbiribindi¹, M. Arvedson¹, J. Pena¹, O. Hatton², C. Esquivel¹, O. Martinez¹, S. Krams¹
¹Department of Surgery/Division of Abdominal Transplantation, Stanford Univ School of Med, Stanford, CA, ²Molecular Biology, Colorado College, Colorado Springs, CO
*Purpose: Epstein-Barr virus (EBV) infects more than 90% of adults worldwide and is associated with several malignancies, including post-transplant lymphoproliferative disorder (PTLD). PTLD is a…